Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00360204 · ClinicalTrials.gov registry record · Phase 3
Improving Health Outcomes for New Mothers and Babies
A Phase 3 study, sponsored by Milton S. Hershey Medical Center.
- Completed
- Registry status
- Phase 3
- Development phase
- 1,154
- Enrollment target
NCT00360204: Completed Phase 3 study, sponsored by Milton S. Hershey Medical Center.
NCT00360204 is a Phase 3 study that has completed, run by Milton S. Hershey Medical Center. The registered enrollment target is 1,154 participants, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (49% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00360204, a Phase 3 study, has completed, sponsored by Milton S. Hershey Medical Center.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 1,154 participants
- Enrollment target
Study Summary
Because adherence to postnatal care guidelines across the United States (U.S.) is poor, newborns and mothers often are placed at undue risk for adverse medical and social outcomes. This study aims to evaluate an alternative model of care and improve healthcare delivery to and reduce health disparities for "well" newborns and mothers after hospital discharge by using single postnatal home nurse visits. The principal investigator has previously shown a reduction in poor outcomes for infants who receive a home visit after discharge when studied retrospectively. The proposed research will build on the previous study and prospectively evaluate the impact of a single home nursing visit on morbidities and health disparities for newborns and mothers in a randomized, controlled trial involving 1154 mother/infant breastfeeding dyads. Home visits should guarantee detailed assessment during an at-risk period of infancy and motherhood, where medical and social problems can be recognized, anticipated, and/or treated, and can bridge the gap between hospital care and primary care. The investigators' program, The Nurses for Infants Through Teaching and Assessment after the NurserY (NITTANY) Initiative, also will consider the cost-effectiveness of home visitation compared with guidelines-adherent outpatient clinic care.
Interventions
- BEHAVIORAL Home Nurse Visit
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,154 participants |
| Start Date | 2006-09 |
| Est. Completion | 2010-02 |
| Phase | Phase 3 |
What the finished NCT00360204 record still lists
NCT00360204 is an interventional study that assigns participants to a tested intervention. Its 1,154 participants enrollment target places it among the larger protocols in the corpus, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (49% higher).
The record links to 0 conditions, and to 1 intervention - of which Home Nurse Visit is the first listed.
NCT00360204 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00360204 about?
NCT00360204 is a clinical study titled "Improving Health Outcomes for New Mothers and Babies". Because adherence to postnatal care guidelines across the United States (U.S.) is poor, newborns and mothers often are placed at undue risk for adverse medical and social outcomes. This study aims to evaluate an alternative model of care and improve healthcare delivery to and reduce health dispariti...
What is the current status of trial NCT00360204?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 1,154 participants. The study started on 2006-09. Estimated completion is 2010-02.
What interventions are being tested in trial NCT00360204?
The interventions under investigation include: Home Nurse Visit (BEHAVIORAL).
Who is sponsoring clinical trial NCT00360204?
This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00360204's enrollment target sits among peer trials
1,154 238th of 2000 higher than 1,763 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04474301 · 1,152 participants
Well-Being and Health-Related Quality of Life in Melanoma Patients During COVID-19 Pandemic
- NCT05564026 · 1,151 participants
Molecular Epidemiology of Pediatric Germ Cell Tumors
- NCT06408181 · 1,150 participants · Phase 3
APPLE: Aspirin to Prevent Pregnancy Loss and Preeclampsia
- NCT06528314 · 1,150 participants · Phase 3
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia